Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 December 2020: Lab/In Vitro Research  

Respiratory Syncytial Virus Infection Reduces Kynurenic Acid Production and Reverses Th17/Treg Balance by Modulating Indoleamine 2,3-Dioxygenase (IDO) Molecules in Plasmacytoid Dendritic Cells

Ling Jin1BCDEF, Qi Hu1BCDF, Ying Hu1BCDF, Zhiqiang Chen1BCDF, Wei Liao1ACDEG*

DOI: 10.12659/MSM.926763

Med Sci Monit 2020; 26:e926763

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) infection causes a world-wide medical and economic burden. This study analyzed the effects of RSV infection on plasmacytoid dendritic cells (pDCs) and evaluated the immunopathogenesis of RSV infection by measuring relative numbers of FoxP3+ Treg cells and Th17 cells.

MATERIAL AND METHODS: pDCs were isolated from human blood samples, purified using magnetic microbeads, and treated with RSV, IFN-g, or vehicle. These cells were mixed with purified CD4+ T cells to yield preparations of pDCs+T cells+vehicle, pDCs+T cells+RSV, and pDCs+T cells+IFN-g. Preparations of pDCs+T cells+RSV were also incubated with an inducer or an inhibitor of indoleamine 2,3-dioxygenase (IDO). Kynurenic acid concentration was measured by high-pressure liquid chromatography (HPLC). The differentiation of Foxp3+ Treg and Th17 cells from CD4+ T cells was determined by flow cytometry.

RESULTS: pDCs were successfully isolated and purified using the magnetic microbeads. Compared with preparations of pDCs+T cells+vehicle, RSV infection (pDCs+T cells+RSV) significantly reduced and IFN-g treatment (pDC+T cells+IFN-g) increased kynurenic acid concentrations and the proportions of Foxp3+ Tregs (p<0.05 each). Conversely, RSV infection increased and IFN-g treatment decreased the proportions of Th17 cells (p<0.05 each). RSV infection reduced kynurenic acid concentrations and inhibited the transformation from Th17 to Foxp3+ Tregs by modulating IDO molecules.

CONCLUSIONS: RSV infection reduced the production of kynurenic acid and inhibited transformation from Th17 to Foxp3+ Tregs (Th17/Treg balance) by modulating IDO molecules in pDCs.

Keywords: Indoleamine-Pyrrole 2,3,-Dioxygenase, kynurenic acid, Respiratory Syncytial Virus Infections, T-Lymphocytes, Regulatory, Cell Separation, Down-Regulation, Forkhead Transcription Factors, Respiratory Syncytial Viruses, Th17 Cells

Background

Respiratory syncytial virus (RSV) infection causes a major world-wide medical and economic burden [1]. RSV, a pneumovirus in the family Paramyxoviridae, is a negative-sense, enveloped, single-stranded RNA virus [2]. Approximately two-thirds of infants are infected with RSV during the first year of life and 95% within 2 years, making RSV the leading cause of childhood hospitalization for illnesses of the respiratory tract [3–5]. Many children who experience severe disorders from RSV infection develop asthma, which can persist to adulthood [6]. The annual financial burden of RSV infection and associated diseases in young children in the USA has been estimated at over 600 million dollars [7].

Natural RSV infection does not induce immunity that blocks RSV re-infection [8]. The pathogenesis of RSV has been associated with the inefficient functions of memory T cells and B cells and their compartments [9,10]. Exposure of immune system cells to RSV antigens induces ineffective or inappropriate RSV-specific immune responses [11]. In addition, RSV can infect cord blood-derived dendritic cells (DCs) by triggering the surface expression of cytokines and biomarkers [12]. Although RSV has been found to infiltrate both myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) [13], the mechanism by which RSV affects the differentiation of FoxP3+ Treg cells and Th17 cells has not been determined.

Interferon (IFN)-γ has been shown to play a critical role in pathogenic pathways induced by RSV infection [14]. Reduction of IFN-γ after RSV infection can attenuate the inflammatory responses of immune cells [15], exacerbating airway diseases. These reductions in IFN-γ, induced by specific antibodies or other drugs, can significantly alleviate RSV-related airway inflammation [16]. Therefore, this study utilized IFN-γ-treated pDCs as positive RSV-infected cells.

This study assessed the effects of RSV infection on pDCs and evaluated the immunopathogenesis of RSV infection by measuring relative numbers of FoxP3+ Treg cells and Th17 cells.

Material and Methods

ISOLATION OF HUMAN PLASMACYTOID DENDRITIC CELLS (PDCS):

Blood samples were collected from healthy blood donors aged >18 years at our hospital. Peripheral blood mononuclear cells (PBMCs) were separated from the blood samples by Ficoll-Paque plus gradient centrifugation, as described previously [17]. pDCs were isolated from PBMCs by positive selection and purification with the CliniMACS CD304 (BDCA-4/Neuropilin-1) Microbead kit (Cat. No. 130-029-101, Mitenyi Biotech., Bergisch Gladbach, Germany), according to the manufacturer’s instructions. The pDCs were cultured in RPMI-1640 medium (Gibco BRL. Co. Ltd., Grand Island, NY, USA) containing 10% fetal bovine serum (FBS; Gibco BRL. Co. Ltd.), L-glutamine (2 mM final concentration, Sigma-Aldrich, St. Louis, MO, USA), and 100 μg/ml streptomycin/100 U/ml penicillin (Sigma-Aldrich).

RSV INFECTION OF PDCS:

Human RSV (type 2) was purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA). The multiplicity of infection (MOI) of RSV stock was evaluated by quantitative plaque-forming assays, as described previously [18], and adjusted to 1×107 plaque-forming units (pfu)/ml [18]. The pDCs were re-suspended at a density of 1×105 cells/ml in culture medium, and 1 ml was added to each well of a 24-well plate. The pDCs were pulsed with ovalbumin (OVA) containing <20 pg/mg lipopolysaccharide (LPS) and stimulated with 10 MOI RSV for 24 h.

ISOLATION OF CD4+ T CELLS:

CD4+ T cells were isolated from PBMC preparations as described previously [19], with a few modifications. Briefly, CD4+CD45RA+ T cells were isolated from PBMCs by negative selection with MACS native CD4+ T cell Isolation Kits (Cat. No. 130-096-533, Mitenyi Biotech) according to the manufacturer’s instructions, and evaluated by flow cytometry on a FACSCalibur (Beckman Coulter, Brea, CA, USA) cell sorter with Flow-Jo software (version: 9.6.2, Flow-Jo LLC, Ashland, OR, USA).

TRIAL GROUPING:

Preparations of 106 pDCs were infected with 10 MOI RSV for 24 h, treated with IFN-γ, or mixed with PBS. Each of these cell preparations was mixed with 106 CD4+ T cells to yield preparations of pDCs+T cells+vehicle, pDCs+T cells+RSV, and pDCs+T cells+IFN-γ. Where indicated, preparations of pDCs+T cells+RSV were treated with 5 μM of the indoleamine 2,3-dioxygenase (IDO) inhibitor 1-methyl-tryptophan (1-MT) [20] or 10 μM of the ISO inducer immunostimulatory sequence oligodeoxynucleotides (ISS-ODN) [21].

KYNURENIC ACID CONCENTRATIONS:

Kynurenic acid concentrations were measured by high-pressure liquid chromatography (HPLC; Waters Co. Ltd., Milford, MA, USA), as described elsewhere [22]. In brief, 20 μl of each pDC supernatant was applied directly to a C18 reverse-phase column (3 μm), and kynurenic acid was eluted isocratically by the mobile phase, consisting of 50 mM sodium acetate, 250 mM zinc acetate, 3% acetonitrile, pH 6.2, at a flow-rate of 1 ml/min. Kynurenic acid in the eluate was measured fluorimetrically, with an excitation wavelength of 344 nm and an emission wavelength of 398 nm, using a fluorescence detector (Model: S200, Perkin-Elmer Co. Ltd., Waltham, MA, USA). In pilot tests, newly produced kynurenic acid was measured with the mobile phase containing 4% acetonitrile. Concentrations of kynurenic acid were calculated from standard curves, as described previously [23].

DIFFERENTIATION OF FOXP3+ TREG AND TH17 CELLS:

Preparations of 106 human pDCs were incubated with 10 μl of APC-labeled mouse anti-human IL-17A antibody (Cat. No. 17-7179-41, eBioscience, Santiago, CA, USA) and 10 μl of PerCP-cyanine 5-labeled mouse anti-human Foxp3 antibody (Cat. No. 45-5773-80, eBioscience) at room temperature for 15 min. The cells were washed and re-suspended in PBS supplemented with 1% FBS (Gibco BRL. Co. Ltd.) and 0.1% NaN3 (Sigma-Aldrich). Cells were evaluated by flow cytometry (FACSCalibur, Beckman Coulter) and analyzed using Flow-Jo software (version: 9.6.2, Flow-Jo LLC). The percentages of total pDCs positive for IL-17 and Foxp3 were determined.

STATISTICAL ANALYSIS:

Results are reported as mean±standard deviation (SD) and compared by Bonferroni post hoc-validated ANOVA tests. All statistical analyses were performed using SPSS software (version: 20.0, SPSS Inc., Chicago, IL, USA), with p<0.05 defined as statistically significant.

Results

SUCCESSFUL ISOLATION AND PURIFICATION OF PDCS:

Flow cytometry showed that incubation of PBMCs with magnetic microbeads markedly increased the percentage of cells positive for the pDC biomarker CD304 to 87% (Figure 1). These findings indicate that this method was successful in the isolation and purification of pDCs.

RSV INFECTION REDUCED KYNURENIC ACID CONCENTRATION IN PDCS:

Based on a standard curve for calculating the concentration of kynurenic acid (Figure 2A), treatment of pDCs with RSV markedly reduced the production of kynurenic acid. HPLC showed that the concentration of kynurenic acid was significantly lower in the pDCs+T cells+RSV supernatants than in the pDCs+T cells+vehicle supernatants (Figure 2B, P<0.05). In contrast, IFN-γ treatment of pDCs enhanced the production of kynurenic acid, with its concentration being significantly higher in the pDCs+T cells+IFN-γ than in the pDCs+T cells+vehicle and pDCs+T cells+RSV supernatants (Figure 2B, P<0.05 each).

:

Flow cytometry analysis of the proportions of Foxp3+ Tregs in the mixed cell preparations (Figure 3A) showed that the proportion of Foxp3+ Tregs was significantly lower in pDCs+T cells+RSV than in pDCs+T cells+vehicle preparations (Figure 3B, P<0.05) and that the proportion of Foxp3+ Tregs was significantly higher in pDCs+T cells+IFN-γ than in pDCs+T cells+vehicle and pDCs+T cells+RSV preparations (Figure 3B, P<0.05 each).

RSV INFECTION UP-REGULATED PROPORTION OF TH17 CELLS:

Flow cytometry analysis (Figure 4A) also showed that the proportion of Th17 cells was significantly higher in pDCs+T cells+RSV than in pDCs+T cells+vehicle preparations (Figure 4B, p<0.05), whereas the proportion of Th17 cells was significantly lower in pDCs+T cells+IFN-γ than in pDCs+T cells+vehicle and pDCs+T cells+RSV preparations (Figure 4B, P<0.05 each).

RSV INFECTION DECREASED KYNURENIC ACID CONCENTRATION THROUGH MODULATING IDO:

To determine the mechanism by which RSV infection reduced kynurenic acid concentrations, pDCs were treated with the IDO inhibitor 1-MT or the IDO inducer ISS-ODN. Kynurenic acid concentrations were significantly lower in pDCs+T cells+RSV preparations treated than in those not treated with the IDO inhibitor 1-MT, but were significantly higher in pDCs+T cells+RSV preparations treated than not treated with the IDO inducer ISS-ODN (Figure 5, P<0.05 each).

:

The effects of IDO inhibition and induction on RSV infection-induced changes in the proportions of Foxp3+ Tregs and Th17 pDCs were also evaluated by flow cytometry (Figure 6A, 6B). Treatment of pDCs+T cells+RSV preparations with IDO inhibitor significantly reduced the proportion of Th17 pDCs while significantly increasing the proportion of Foxp3+ Tregs (Figure 6C, P<0.05 each). Conversely, treatment of pDCs+T cells+RSV preparations with IDO inducer significantly increased the proportion of Foxp3+ Tregs while significantly reducing the proportion of proportion of Th17 pDCs (Figure 6C, P<0.05 each).

Discussion

RSV, a member of the Paramyxoviridae family, causes respiratory morbidity in both elderly individuals and infants [24]. RSV has been shown isocratically to activate human DCs and induce the production of immunomodulatory cytokines [25], including both the Th1-type cytokine IFN-γ and Th2-type cytokines [26]. Moreover, the functions of pDCs in respiratory viral infections have not been fully clarified. Therefore, the present study assessed the pathological mechanisms of RSV infection in pDCs.

The kynurenine pathway has been shown to modulate tryptophan metabolism and the serotonergic system and to play critical roles in the secretion of pro-inflammatory cytokines [27]. In the kynurenine metabolic pathway, tryptophan is initially oxygenated by IDO to yield kynurenine, which is subsequently transformed by kynurenine aminotransferase to kynurenic acid [28]. Our findings showed that RSV infection markedly reduced kynurenic acid concentrations in pDCs, suggesting that RSV infection can modulate inflammatory responses in pDCs by regulating the production of kynurenic acid.

The anti-inflammatory effects of kynurenic acid have been found to correlate with the modulation of immune responses in DCs undergoing pro-inflammatory stimulation [29]. Similarly, the Th1/Th2 balance in cell immune responses, especially the balance between Tregs and Th17 cells, plays critical roles in various infectious diseases and nervous system disorders [30,31]. Thus, changes in Foxp3+ Treg cells and Th17 cells in pDCs in response to RSV infection were assessed by flow cytometry. Our findings indicated that RSV infection reduced the proportion of Foxp3+ Treg cells and increased the proportion of Th17 cells. Because RSV infection is associated with a Th1-type immune response, including the secretion of IFN-γ [32], we also tested the effects of IFN-γ treatment on the balance between Tregs and Th17 cells [32]. We found that IFN-γ increased the proportion of Foxp3+ Tregs while reducing the proportion of Th17 cells. These findings suggest that IFN-γ promotes the transformation from Th17 cells to Foxp3+ Treg cells, whereas RSV infection suppresses this transformation, altering the Th17/Treg balance.

IDO is a rate-limiting enzyme in the synthesis of tryptophan-related metabolites such as kynurenic acid. IDO expression can be induced by inflammatory cytokines [33]. Disorders can be treated by altering the metabolism and/or balance of immune system cells, thereby modulating immune responses [34,35]. One example may be the ability of IDO activity to modulate tryptophan metabolism. Treatment of pDCs with the IDO inhibitor 1-MT or the IDO inducer ISS-ODN affected both kynurenic acid production and the Th17/Treg balance. Kynurenic acid concentration was significantly reduced by the IDO inhibitor and significantly enhanced by the IDO inducer, suggesting that RSV infection decreased kynurenic acid concentration by modulating IDO activity. In addition, the proportion of T cell-derived Foxp3+ Tregs was significantly reduced by IDO inhibitor, but was significantly increased by IDO inducer. Conversely, the proportion of Th17 cells was significantly increased by IDO inhibitor but was significantly reduced by IDO inducer, suggesting that RSV infection inhibited the transformation from Th17 to Foxp3+ Tregs by modulating IDO activity.

Conclusions

To the best of our knowledge, this study is the first to clarify changes in kynurenic acid resulting from RSV infection of human pDCs. We found that RSV infection decreased kynurenic acid concentration and altered the balance between Th17 and FoxP3+ Treg cells. IDO inhibitor reduced kynurenic acid concentration, whereas IDO inducer increased its concentration in RSV-infected pDCs. In summary, RSV infection reduced production of kynurenic acid and inhibited the transformation from Th17 to Foxp3+ Tregs (Th17/Treg balance) by altering IDO activity in pDCs.

Figures

Magnetic microbead method of purifying pDCs. pDCs were assessed in cell preparations by flow cytometry analysis of expression of the biomarker CD304.Figure 1. Magnetic microbead method of purifying pDCs. pDCs were assessed in cell preparations by flow cytometry analysis of expression of the biomarker CD304. Determination of kynurenic acid concentrations in pDCs infected with RSV. (A) Standard curve for calculating kynurenic acid concentration. (B) Kynurenic acid concentrations in mixtures of pDCs and T cells. * P<0.05 compared with pDCs+T cells+vehicle. # p<0.05 compared with pDCs+T cells+RSV.Figure 2. Determination of kynurenic acid concentrations in pDCs infected with RSV. (A) Standard curve for calculating kynurenic acid concentration. (B) Kynurenic acid concentrations in mixtures of pDCs and T cells. * P<0.05 compared with pDCs+T cells+vehicle. # p<0.05 compared with pDCs+T cells+RSV. Effects of RSV infection on proportions of Foxp3+ Tregs derived from CD4+ T cells. (A) Flow cytometry analyses of Foxp3+ Treg cells in preparations of pDCs+T cells+vehicle, pDCs+T cells+RSV and pDCs+T cells+IFN-γ. (B) Statistical comparison of proportions of Foxp3+ Treg cells in these preparations. * P<0.05 compared with pDCs+T cells+vehicle. # P<0.05 compared with pDCs+T cells+RSV.Figure 3. Effects of RSV infection on proportions of Foxp3+ Tregs derived from CD4+ T cells. (A) Flow cytometry analyses of Foxp3+ Treg cells in preparations of pDCs+T cells+vehicle, pDCs+T cells+RSV and pDCs+T cells+IFN-γ. (B) Statistical comparison of proportions of Foxp3+ Treg cells in these preparations. * P<0.05 compared with pDCs+T cells+vehicle. # P<0.05 compared with pDCs+T cells+RSV. Effects of RSV infection on proportions of Th17 cells derived from CD4+ T cells. (A) Flow cytometry analyses of Th17 cells in preparations of pDCs+T cells+vehicle, pDCs+T cells+RSV and pDCs+T cells+IFN-γ. (B) Statistical comparison of proportions of Th17 cells in these preparations. * P<0.05 compared with pDCs+T cells+vehicle. # P<0.05 compared with pDCs+T cells+RSV.Figure 4. Effects of RSV infection on proportions of Th17 cells derived from CD4+ T cells. (A) Flow cytometry analyses of Th17 cells in preparations of pDCs+T cells+vehicle, pDCs+T cells+RSV and pDCs+T cells+IFN-γ. (B) Statistical comparison of proportions of Th17 cells in these preparations. * P<0.05 compared with pDCs+T cells+vehicle. # P<0.05 compared with pDCs+T cells+RSV. Effects of IDO inhibitor and IDO inducer on kynurenic acid concentrations in RSV-infected pDCs. * P<0.05 compared with pDCs+T cells+vehicle. # P<0.05 compared with pDCs+T cells+RSV.Figure 5. Effects of IDO inhibitor and IDO inducer on kynurenic acid concentrations in RSV-infected pDCs. * P<0.05 compared with pDCs+T cells+vehicle. # P<0.05 compared with pDCs+T cells+RSV. Effects of IDO inhibitor and IDO inducer on Foxp3+ Treg/Th17 balance in RSV-infected pDCs. (A, B). Flow cytometry analyses of the proportions of (A) Foxp3+ Tregs and (B) Th17 in pDC preparations. (C) Statistical analysis of the ratios of Foxp3+ Treg to Th17 cells in pDCs. * P<0.05 compared with pDCs+T cells+vehicle. # p<0.05 compared with pDCs+T cells+RSV.Figure 6. Effects of IDO inhibitor and IDO inducer on Foxp3+ Treg/Th17 balance in RSV-infected pDCs. (A, B). Flow cytometry analyses of the proportions of (A) Foxp3+ Tregs and (B) Th17 in pDC preparations. (C) Statistical analysis of the ratios of Foxp3+ Treg to Th17 cells in pDCs. * P<0.05 compared with pDCs+T cells+vehicle. # p<0.05 compared with pDCs+T cells+RSV.

References

1. Cormier SA, Shrestha B, Saravia J, Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection: J Virol, 2014; 88(16); 9350-60

2. Collins PL, Graham BS, Viral and host factors in human respiratory syncytial virus pathogenesis: J Virol, 2008; 82(5); 2040-55

3. Hall CB, Respiratory syncytial virus and parainfluenza virus: N Engl J Med, 2001; 344(25); 1917-28

4. Ge X, Guo Y, Chen J, Epidemiology and seasonality of respiratory viruses detected from children with respiratory tract infections in Wuxi, East China: Med Sci Monit, 2018; 24; 1856-62

5. Glezen WP, Taber LH, Frank AL, Kasel JA, Risk of primary infection and reinfection with respiratory syncytial virus: Am J Dis Child, 1986; 140(6); 543-46

6. Sigurs N, Aljassim F, Kjellman B, Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life: Thorax, 2010; 65(12); 1045-52

7. Paramore LC, Ciuryla V, Ciesla G, Liu L, Economic impact of respiratory syncytial virus-related illness in the US: An analysis of national databases: Pharmacoeconomics, 2004; 22(5); 278-84

8. Hall CB, Long CE, Schnabel KC, Respiratory syncytial virus infections in previously healthy working adults: Clin Inf Dis, 2001; 33(6); 792-96

9. Singleton R, Etchart N, Hou S, Hyland L, Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody response: J Virol, 2003; 77(21); 11303-11

10. Johnson TR, Johnson CN, Corbett KS, Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus: PLoS One, 2011; 6(1); e16458

11. Kinnear E, Lambert L, McDonald JU, Airway T cells protect against RSV infection in the absence of antibody: Mucosal Immunol, 2018; 11(1); 249-56

12. Schauer U, Hoffjan S, Rothoeft T: Clin Exp Immunol, 2004; 138(1); 102-9

13. Gill MA, Long K, Kwon T, Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection: J Infect Dis, 2008; 198(11); 1667-76

14. Long X, Li S, Xie J, MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice: Respir Res, 2015; 16(1); 11

15. Zang N, Xie X, Deng Y, Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice: J Virol, 2011; 85(24); 13061-68

16. Liu T, Zang N, Zhou N, Resveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection: J Virol, 2014; 88(8); 4229-36

17. Fekete T, Suto MI, Bencze D, Human plasmacytoid and monocyte-derived dendritic cells display distinct metabolic profile upon RIG-I activation: Front Immunol, 2018; 9; 3070

18. Boelen A, Andeweg A, Kwakkel J, Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice: Vaccine, 2000; 19(7–8); 982-91

19. Flaherty S, Reynolds JM: J Vis Exp, 2015(98); 52739

20. Wang Y, Lv S, Wang Q, Mechanisms underlying immune tolerance caused by recombinant Echinococcus granulosus antigens Eg mMDH and Eg10 in dendritic cells: PLoS One, 2018; 13(9); e0204868

21. Yang Y, Liu K, Chen Y, Indoleamine 2,3-dioxygenase (IDO) regulates Th17/Treg immunity in experimental IgA nephropathy: Folia Biol (Praha), 2019; 65(2); 101-8

22. Oades RD, Myint AM, Dauvermann MR, Attention-deficit hyperactivity disorder (ADHD) and glial integrity: An exploration of associations of cytokines and kynurenine metabolites with symptoms and attention: Behav Brain Funct, 2010; 6; 32

23. Shibata K, Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography: J Chromatogr, 1988; 430(2); 376-80

24. Chen X, Luo Y, Wang M, Wuhu decoction regulates dendritic cell autophagy in the treatment of respiratory syncytial virus (RSV)-induced mouse asthma by AMPK/ULK1 signaling pathway: Med Sci Monit, 2019; 25; 5389-400

25. Guerrero-Plata A, Casola A, Suarez G, Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus: Am J Respir Cell Mol Biol, 2006; 34(3); 320-29

26. Smit JJ, Rudd BD, Lukacs NW, Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus: J Exp Med, 2006; 203(5); 1153-59

27. Andre C, O’Connor JC, Kelley KW, Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration: J Neuroimmunol, 2008; 200(1–2); 90-99

28. Kotlinska-Hasiec E, Nowicka-Stazka P, Parada-Turska J, Plasma kynurenic acid concentration in patients undergoing cardiac surgery: Effect of anaesthesia: Arch Immunol Ther Exp (Warsz), 2015; 63(2); 129-37

29. Mandi Y, Vecsei L, The kynurenine system and immunoregulation: J Neural Transm (Vienna), 2012; 119(2); 197-209

30. Alunno A, Bartoloni E, Bistoni O, Balance between regulatory T and Th17 cells in systemic lupus erythematosus: The old and the new: Clin Dev Immunol, 2012; 2012 823085

31. Gao YR, Chen WW, Li JW, Zou HLTreg/Th17 balance and immunology of schistosome infection: A review: Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, 2018; 30(5); 588-91 [in Chinese]

32. Barends M, Boelen A, de Rond L, Influence of respiratory syncytial virus infection on cytokine and inflammatory responses in allergic mice: Clin Exp Allergy, 2002; 32(3); 463-71

33. Cole JE, Astola N, Cribbs AP, Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development: Proc Natl Acad Sci USA, 2015; 112(42); 13033-38

34. Chang CH, Pearce EL, Emerging concepts of T cell metabolism as a target of immunotherapy: Nat Immunol, 2016; 17(4); 364-68

35. Munn DH, Mellor AL, Indoleamine 2,3 dioxygenase and metabolic control of immune responses: Trends Immunol, 2013; 34(3); 137-43

Figures

Figure 1. Magnetic microbead method of purifying pDCs. pDCs were assessed in cell preparations by flow cytometry analysis of expression of the biomarker CD304.Figure 2. Determination of kynurenic acid concentrations in pDCs infected with RSV. (A) Standard curve for calculating kynurenic acid concentration. (B) Kynurenic acid concentrations in mixtures of pDCs and T cells. * P<0.05 compared with pDCs+T cells+vehicle. # p<0.05 compared with pDCs+T cells+RSV.Figure 3. Effects of RSV infection on proportions of Foxp3+ Tregs derived from CD4+ T cells. (A) Flow cytometry analyses of Foxp3+ Treg cells in preparations of pDCs+T cells+vehicle, pDCs+T cells+RSV and pDCs+T cells+IFN-γ. (B) Statistical comparison of proportions of Foxp3+ Treg cells in these preparations. * P<0.05 compared with pDCs+T cells+vehicle. # P<0.05 compared with pDCs+T cells+RSV.Figure 4. Effects of RSV infection on proportions of Th17 cells derived from CD4+ T cells. (A) Flow cytometry analyses of Th17 cells in preparations of pDCs+T cells+vehicle, pDCs+T cells+RSV and pDCs+T cells+IFN-γ. (B) Statistical comparison of proportions of Th17 cells in these preparations. * P<0.05 compared with pDCs+T cells+vehicle. # P<0.05 compared with pDCs+T cells+RSV.Figure 5. Effects of IDO inhibitor and IDO inducer on kynurenic acid concentrations in RSV-infected pDCs. * P<0.05 compared with pDCs+T cells+vehicle. # P<0.05 compared with pDCs+T cells+RSV.Figure 6. Effects of IDO inhibitor and IDO inducer on Foxp3+ Treg/Th17 balance in RSV-infected pDCs. (A, B). Flow cytometry analyses of the proportions of (A) Foxp3+ Tregs and (B) Th17 in pDC preparations. (C) Statistical analysis of the ratios of Foxp3+ Treg to Th17 cells in pDCs. * P<0.05 compared with pDCs+T cells+vehicle. # p<0.05 compared with pDCs+T cells+RSV.

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750